Your browser doesn't support javascript.
loading
Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+ Invasive Breast Cancer.
Yamada, Mai; Kubo, Makoto; Yamamoto, Hidetaka; Yamashita, Nami; Kai, Masaya; Zaguirre, Karen; Kaneshiro, Kazuhisa; Shimazaki, Akiko; Hayashi, Saori; Kawaji, Hitomi; Mori, Masaki; Oda, Yoshinao; Nakamura, Masafumi.
Afiliação
  • Yamada M; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Kubo M; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan mkubo@surg1.med.kyushu-u.ac.jp.
  • Yamamoto H; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Yamashita N; Department of Surgery and Science, Kyushu University, Fukuoka, Japan.
  • Kai M; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Zaguirre K; Institute of Surgery, St. Luke's Medical Center, Quezon, Philippines.
  • Kaneshiro K; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Shimazaki A; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Hayashi S; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Kawaji H; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Mori M; Department of Surgery and Science, Kyushu University, Fukuoka, Japan.
  • Oda Y; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Nakamura M; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Anticancer Res ; 41(8): 4143-4149, 2021 Aug.
Article em En | MEDLINE | ID: mdl-34281885

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article